Cargando…
Immunotherapy-induced antibodies to endogenous retroviral envelope glycoprotein confer tumor protection in mice
Following curative immunotherapy of B16F10 tumors, ~60% of mice develop a strong antibody response against cell-surface tumor antigens. Their antisera confer prophylactic protection against intravenous challenge with B16F10 cells, and also cross-react with syngeneic and allogeneic tumor cell lines M...
Autores principales: | Kang, Byong H., Momin, Noor, Moynihan, Kelly D., Silva, Murillo, Li, Yingzhong, Irvine, Darrell J., Wittrup, K. Dane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049297/ https://www.ncbi.nlm.nih.gov/pubmed/33857179 http://dx.doi.org/10.1371/journal.pone.0248903 |
Ejemplares similares
-
Antibody-induced internalisation of retroviral envelope glycoproteins is a signal initiation event
por: Panova, Veera, et al.
Publicado: (2020) -
Antigenicity of peptides comprising the immunosuppressive domain of the retroviral envelope glycoprotein
por: Jenkins, Bryony, et al.
Publicado: (2017) -
Characterization of the fusion core in zebrafish endogenous retroviral envelope protein
por: Shi, Jian, et al.
Publicado: (2015) -
Mutation of the Putative Immunosuppressive Domain of the Retroviral Envelope Glycoprotein Compromises Infectivity
por: Eksmond, Urszula, et al.
Publicado: (2017) -
Maximizing response to intratumoral immunotherapy in mice by tuning local retention
por: Momin, Noor, et al.
Publicado: (2022)